
EnteroMedicsOrchestrating Obesity Solutions
Implantable System Under Clinical Investigation as a Treatment for ObesityEnteroMedics Inc. is developing implantable systems to treat obesity and other gastrointestinal disorders. Its VBLOC™ Therapy is designed to precisely control, or “neuroregulate”, nerve and organ function. The vagal nerves regulate much of the activity of the stomach and the pancreas and are also believed to play a significant role in the signaling of satiety and hunger. VBLOC Therapy delivers high frequency, low energy electrical signals through laparoscopically implanted leads to block vagal nerve transmission. The delivery of energy to the nerves is intermittent and the effects of VBLOC Therapy on the nerves and end organs are intended to be reversible. The system is designed to be precisely programmed and non-invasively adjusted to meet individual needs. Unlike the majority of existing surgical obesity treatments, normal digestive system anatomy is preserved. Clinical trials are intended to show that VBLOC Therapy will help those who are morbidly obese manage their weight. Currently available surgical obesity treatments such as gastric bypass surgery and laparoscopic banding alter normal anatomy to reduce stomach size. Clinical studies will demonstrate if VBLOC Therapy offers a safe and effective alternative to the well known complications associated with existing approaches to bariatric surgery. VBLOC Therapy is undergoing clinical investigation for obesity treatment at select centers within and outside the United States. VBLOC Therapy is not yet available or approved for use in the United States.
Home |
What is VBLOC Therapy? |
Why VBLOC Therapy?
|
